| Group a streptococcal diseases and their global burden AP Ralph, JR Carapetis Host-pathogen interactions in streptococcal diseases, 1-27, 2012 | 393 | 2012 |
| A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis AP Ralph, M Ardian, A Wiguna, GP Maguire, NG Becker, G Drogumuller, ... Thorax 65 (10), 863-869, 2010 | 260 | 2010 |
| The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease AP Ralph, S Noonan, V Wade, BJ Currie Medical Journal of Australia 214 (5), 220-227, 2021 | 199* | 2021 |
| Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 184 | 2020 |
| Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial JS Davis, A Sud, MVN O'Sullivan, JO Robinson, PE Ferguson, H Foo, ... Clinical Infectious Diseases 62 (2), 173-180, 2016 | 182 | 2016 |
| The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review PM Coffey, AP Ralph, VL Krause PLoS neglected tropical diseases 12 (6), e0006577, 2018 | 166 | 2018 |
| Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations LJ Zühlke, A Beaton, ME Engel, CT Hugo-Hamman, G Karthikeyan, ... Current treatment options in cardiovascular medicine 19, 1-23, 2017 | 163 | 2017 |
| Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis AP Ralph, RM Lucas, M Norval The Lancet infectious diseases 13 (1), 77-88, 2013 | 128 | 2013 |
| L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial AP Ralph, G Waramori, GJ Pontororing, E Kenangalem, A Wiguna, ... PloS one 8 (8), e70032, 2013 | 126 | 2013 |
| Mortality attributable to Plasmodium vivaxmalaria: a clinical audit from Papua, Indonesia NM Douglas, GJ Pontororing, DA Lampah, TW Yeo, E Kenangalem, ... BMC medicine 12 (1), 217, 2014 | 112 | 2014 |
| High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena AP Ralph, E Kenangalem, G Waramori, GJ Pontororing, Sandjaja, E Tjitra, ... PloS one 8 (11), e80302, 2013 | 112 | 2013 |
| Long-term outcomes from acute rheumatic fever and rheumatic heart disease: a data-linkage and survival analysis approach VYF He, JR Condon, AP Ralph, Y Zhao, K Roberts, JL de Dassel, ... Circulation 134 (3), 222-232, 2016 | 93 | 2016 |
| Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data DA Jolliffe, D Ganmaa, C Wejse, R Raqib, MA Haq, N Salahuddin, ... European Respiratory Journal 53 (3), 2019 | 92 | 2019 |
| Transmission of Burkholderia pseudomallei via breast milk in northern Australia A Ralph, J McBride, BJ Currie The Pediatric infectious disease journal 23 (12), 1169-1171, 2004 | 92 | 2004 |
| Diagnosing tuberculous meningitis–have we made any progress? J Ho, BJ Marais, GL Gilbert, AP Ralph Tropical Medicine & International Health 18 (6), 783-793, 2013 | 89 | 2013 |
| L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis AP Ralph, PM Kelly, NM Anstey Trends in microbiology 16 (7), 336-344, 2008 | 87 | 2008 |
| Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change JM Katzenellenbogen, D Bond‐Smith, RJ Seth, K Dempsey, J Cannon, ... Journal of the American Heart Association 9 (19), e016851, 2020 | 86 | 2020 |
| The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation BJ Currie, M Mayo, LM Ward, M Kaestli, EM Meumann, JR Webb, ... The Lancet infectious diseases 21 (12), 1737-1746, 2021 | 85 | 2021 |
| Community-based participatory action research on rheumatic heart disease in an Australian Aboriginal homeland: Evaluation of the ‘On track watch’project E Haynes, M Marawili, BM Marika, AG Mitchell, J Phillips, D Bessarab, ... Evaluation and program planning 74, 38-53, 2019 | 67 | 2019 |
| How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease JL de Dassel, N de Klerk, JR Carapetis, AP Ralph Journal of the American Heart Association 7 (24), e010223, 2018 | 63 | 2018 |
Jonathan CarapetisDirector, Telethon Kids InstituteVerified email at telethonkids.org.au
